Clinical Trial Update: Pramipexole for Anhedonic Depression [Phase 3]

View source ↗

Summary

Pramipexole is being studied in a Phase 3 trial for anhedonic depression. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Pramipexole (pramipexole)

Snippet

Sponsor: Region Skane | Conditions: Psychiatric Disorders Mood, Anhedonia | Phase 3 | Status: ACTIVE_NOT_RECRUITING